Daniela E Oprea-Lager
Overview
Explore the profile of Daniela E Oprea-Lager including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
2874
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Henrar R, Vuijk F, Burchell G, van Dieren S, de Geus-Oei L, Kazemier G, et al.
Int J Mol Sci
. 2025 Mar;
26(5).
PMID: 40076605
Radiolabelled fibroblast activation protein inhibitor (FAPI) tracers have the potential to overcome the limitations of 2-deoxy-2-[F]fluoro-D-glucose ([F]FDG) and improve the diagnosis and staging of hepato-pancreato-biliary (HPB) cancers. This study aims...
2.
Knip J, Iqbal R, Bonjer E, Mammatas L, van Zweeden A, Perin P, et al.
Radiology
. 2025 Mar;
314(3):e241850.
PMID: 40035673
Background According to current guidelines, staging of patients with locally advanced breast cancer and local-regional recurrent breast cancer is preferably performed with PET using 2-fluorine 18-fluoro-2-deoxy-d-glucose (F-FDG). However, F-FDG PET...
3.
van der Gaag S, Vis A, Bartelink I, Koppes J, Hodolic M, Hendrikse H, et al.
J Nucl Med
. 2025 Feb;
66(3):373-376.
PMID: 39915123
Androgen receptor-targeting agents, particularly enzalutamide, show promise in enhancing prostate cancer diagnostic and therapeutic strategies by modulating prostate-specific membrane antigen (PSMA). A retrospective clinical cohort study investigated 9 men with...
4.
van Geel J, Moustaquim J, Boers J, Elias S, Smeets E, Knip J, et al.
J Nucl Med
. 2025 Jan;
66(2):194-200.
PMID: 39848768
Intrapatient heterogeneity of estrogen receptor (ER) expression on 16α-[F]fluoro-17β-estradiol ([F]FES) PET is related to outcome in patients with ER-positive metastatic breast cancer (MBC), but a validated and practical method to...
5.
Puik J, Poels T, Hooijer G, Cysouw M, Verheij J, Wilmink J, et al.
Cancer Imaging
. 2025 Jan;
25(1):2.
PMID: 39810252
Background: Current diagnostic imaging modalities have limited ability to differentiate between malignant and benign pancreaticobiliary disease, and lack accuracy in detecting lymph node metastases. F-Prostate-Specific Membrane Antigen (PSMA) PET/CT is...
6.
Palard-Novello X, Henrar R, Oprea-Lager D, Cysouw M, Schober P, de Geus-Oei L, et al.
Eur J Nucl Med Mol Imaging
. 2025 Jan;
52(4):1472-1480.
PMID: 39743615
Purpose: The aim of this study was to validate simplified methods for quantifying [Ga]Ga-FAPI-46 uptake against full pharmacokinetic modeling. Methods: Ten patients with pancreatobiliary cancer underwent a 90-min dynamic PET/CT...
7.
Stranne J, Henry A, Oprea-Lager D
Eur Urol
. 2024 Dec;
87(2):108-109.
PMID: 39701872
Trials have shown that prostate-specific membrane antigen (PSMA)-based positron emission tomography/computed tomography (PET/CT) is more accurate than conventional imaging for staging of nodal status in prostate cancer. We discuss the...
8.
Ettema R, Mellema J, Meijer D, Oudshoorn F, Luining W, van Leeuwen P, et al.
Eur Urol Oncol
. 2024 Dec;
PMID: 39694797
Background And Objective: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) is increasingly used for primary staging in prostate cancer. Owing to accurate detection of small metastases on PSMA-PET/CT,...
9.
Hope T, Calais J, Goenka A, Haberkorn U, Konijnenberg M, McConathy J, et al.
J Nucl Med
. 2024 Nov;
66(1):26-33.
PMID: 39572227
No abstract available.
10.
Puik J, Le C, Kazemier G, Oprea-Lager D, Swijnenburg R, Giovannetti E, et al.
Crit Rev Oncol Hematol
. 2024 Nov;
205:104556.
PMID: 39551117
Prostate-specific membrane antigen (PSMA) is one of the few biomarkers which has been successfully translated to the clinic as theranostic biomarker for patients with prostate cancer. In the context of...